Malika Amin โ€” Managing Director & CEO of Alembic, Pragmatic CEO

Malika Amin

#989
Managing Director & CEO
70
Age
37y
Exp
37y
Tenure
5/10
Risk
PragmaticLadder-ClimberSmall Cap
๐ŸŽ“ B.A.
๐Ÿ“œ M.A.
๐Ÿ›๏ธ None
CompensationTBP
Personality
Openness โ€” Creativity, curiosity, willingness to try new ideasOpenConscientiousness โ€” Discipline, organization, attention to detailConscExtraversion โ€” Social energy, assertiveness, enthusiasmExtraAgreeableness โ€” Cooperation, trust, empathyAgreeNeuroticism โ€” Emotional sensitivity, stress reactivityNeuro
5
Open
7
Cons
4
Extr
5
Agre
4
Neur
Alembic
Alembic
Real Estate ยท Small Cap
Pace โ€” Speed of execution and decision-making intensityPaceInnovation โ€” Appetite for disruption vs incremental improvementInnovCulture โ€” Organizational culture type and valuesCultrEfficiency โ€” Operational and capital efficiency focusEfficPurpose โ€” Balance of profit motive vs social missionPurpsBrand โ€” External brand positioning and market perceptionBrand
Mature Stable ยท Hierarchical
About
Malika Amin is the Managing Director & CEO of Alembic, a Small Cap company in the Real Estate sector with a market cap of โ‚น2K Cr. A Pragmatic leader with 37 years of experience, she is known for authority-driven decision-making and organic builder strategy. Maintains a disciplined, steady approach to pharmaceutical market penetration with a focus on core therapeutic segments.
FAQ
What is Malika Amin's leadership style?
Malika Amin is classified as a Pragmatic leader. She is authority-driven in decision-making, with a shareholder champion motivation and steady-marathon pace of execution.
What is Malika Amin's educational background?
Malika Amin holds a B.A. and a M.A..
Who is the CEO of Alembic?
Malika Amin is the Managing Director & CEO of Alembic. She has been with the company for 37 years and in the current role for 7 years.

Leadership DNA

ArchetypePragmatic
MotivationShareholder Champion
CrisisSteady Hand
DecisionAuthority-Driven
GrowthOrganic Builder
PeopleInstitution Builder
InnovationTraditionalist
PaceSteady-Marathon
PurposeProfit-Pure
CustomerMass-Consumer
EmployerSteady Employer
BrandTrusted
FocusOperational Excellence
OrientationDeep Specialist

Leadership Evidence

โ€œMaintains a disciplined, steady approach to pharmaceutical market penetration with a focus on core therapeutic segments.โ€
โšก Crisisโ—โ—โ—โ—โ—‹
Maintains consistent operational stability and disciplined execution in a volatile real estate market.
๐ŸŽฏ Motivationโ—โ—โ—โ—โ—‹
Focuses on consistent value creation and transparent corporate governance for stakeholders.
๐Ÿ‘ฅ Peopleโ—โ—โ—โ—โ—‹
Prioritizes long-term organizational health and robust internal processes over short-term gains.
๐Ÿ“ˆ Growthโ—โ—โ—โ—โ—
Prefers steady, project-based growth and internal capacity building over aggressive M&A.
๐Ÿ’ก Innovationโ—โ—โ—โ—โ—‹
The company focuses on long-standing real estate development projects in Vadodara with a conservative approach to land development rather than disruptive innovation.
๐Ÿƒ Paceโ—โ—โ—โ—โ—‹
As a legacy real estate entity, its operational tempo is defined by the multi-year, methodical execution of residential and commercial projects.
๐ŸŒฑ Purposeโ—โ—โ—โ—‹โ—‹
The company maintains a standard compliance-based approach to CSR typical of small-cap real estate developers without significant ESG-led public branding.
๐Ÿท๏ธ Brandโ—โ—โ—โ—โ—‹
The company leverages its long history and established presence in the Vadodara real estate market to build reliability and institutional credibility with local buyers.
๐Ÿค Customerโ—โ—โ—โ—โ—‹
The company primarily develops residential townships and commercial spaces aimed at the local urban consumer market in Gujarat.
๐Ÿ’ผ Employerโ—โ—โ—โ—‹โ—‹
Its reputation as a long-standing, stable regional developer suggests a culture of longevity and predictable, process-driven work environments.
๐Ÿ“‹ Mandate
The company needs to focus on capital discipline and efficient execution of legacy real estate projects to maintain stability in a competitive market.
๐Ÿข Cultureโ—โ—โ—โ—‹โ—‹
Long-standing promoter-led conglomerate culture with formalized, established reporting lines.

Financials

Revenue FY25โ‚น211 Cr
PAT FY25โ‚น311 Cr
Rev CAGR 5Y43.6%
OPM39.3%
NPM147.1%
ROE13.3%
ROCE3.5%
P/E6.5
Fwd P/Eโ€”
P/B0.8
D/E0.5
Promoter72.2%
Institutional0.9%
Mkt Capโ‚น2K Cr
Compensation
To Be Published
Data being verified from audited reports